205
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM

&
Pages 101-110 | Received 08 Nov 1995, Accepted 29 Dec 1995, Published online: 10 Jul 2009

References

  • Bloemmen J, Eyssen H. Immunoglobulin levels of sera of genetically thymusless (nude) mice. Eur J Immunol 1973; 3: 117–118
  • Bosma G C, Custer R P, Bosma M J. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527–530
  • Bosma G C, Fried M, Custer R P, Carroll A, Gibson D M, Bosma M J. Evidence of functional lymphocytes in some (leaky) scid mice. J Exp Med 1988; 167: 1016–1033
  • Buchmeier M J, Lewicki H A, Talbot P J, Knobler R L. Murine hepatitis virus-4 (Strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 1984; 132: 261–270
  • Burns W H, Billups L C, Notions A L. Thymus dependence of viral antigens. Nature 1975; 256: 654–656
  • Cardell S, Merkenschlager M, Bodmer H, Chan S, Cosgrove D, Benoist C, Mathis D. The immune system of mice lacking conventional MHC class II molecules. Adv Immunol 1994; 55: 423–440
  • Compton S R, Barthold S W, Smith A L. The cellular and molecular pathogenesis of corona-viruses. Lab Anim Sci 1993; 43: 15–28
  • Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C, Mathis D. Mice lacking MHC class II molecules. Cell 1991; 66: 1051–1066
  • Dal Canto M C. Handbook of Multiple Sclerosis. Marcel Dekker, Inc., New York 1990; 63–100, Experimental models of virus-induced demyelination. In Cook, SD (ed)
  • Dal Canto M C, Rabinowitz S G. Experimental models of virus-induced demyelination of the central nervous system. Ann Neurol 1981; 11: 109–127
  • Dörries R, Schwender S, Imrich H, Harms H. Population dynamics of lymphocyte subsets in the central. nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis. Immunology 1991; 74: 539–545
  • Dorshkind K, Keller G M, Phillips R A, Miller R G, Bosma G C, O'Toole M, Bosma M J. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J. Immunol 1984; 132: 1804–1808
  • Fazakerley J K, Buchmeier M J. Pathogenesis of virus-induced demyelination. Adv Virus Res 1993; 42: 249–324
  • Fazakerley J K, Parker S E, Bloom F, Buchmeier M J. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology 1992; 187: 178–188
  • Fleming J O, Pen L B. Measurement of the concentration of murine IgG monoclonal antibody in hybridoma supernatants and ascites in absolute units by sensitive and reliable enzyme-linked immunosorbent assays (ELISA). J Immunol Meth 1988; 110: 11–18
  • Fleming J O, Shubin R A, Sussman M A, Casteel N, Stohlman S A. Monoclonal antibodies to the matrix (El) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 1989; 168: 162–167
  • Fleming J O, Trousdale M D, Bradbury J, Stohlman S A, Weiner L P. Experimental demyelination induced by coronavirus JHM (MHV-4): Molecular identification of a viral determinant of paralytic disease. Microb Pathog 1987; 3: 9–20
  • Fleming J O, Trousdale M D, El-Zaatari F AK, Stohlman S A, Weiner L P. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol 1986; 58: 869–875
  • Fleming J O, Wang F I, Trousdale M D, Hinton D R, Stohlman S A. Interaction of immune and central nervous systems: Contribution of antiviral Thy-1+ cells to demyelination induced by coronavirus JHM. Reg Immunol 1993; 5: 37–43
  • Gombold J L, Sutherland R M, Lavi E, Paterson Y, Weiss S R. Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells. Microb Pathog 1995; 18: 211–221
  • Jacobsen G, Perlman S. Coronaviruses and Their Diseases. Plenum Press, New York 1990; 573–578, Localization of virus and antibody response in mice infected persistently with MHV-JHM. In: Cavanagh D, Brown TDK, (eds)
  • Kennedy J D, Pierce C W, Lake J P. Extrathymic T cell maturation. Phenotypic analysis of T cell subsets in nude mice as a function of age. J. Immunol 1992; 148: 1620–1629
  • Kindred B. Immunologic Defects in Laboratory Animals. Plenum Press, New York 1981; 215–265, Deficient and sufficient immune systems in the nude mouse. In: Gershwin ME, Merchant B, (eds)
  • Kirchgessner C U, Patil C K, Evans J W, Cuomo C A, Fried L M, Carter T, Oettinger M A, Brown J M. DNA-dependent kinase (p350) as a candidate gene for the murine SCDD defect. Science 1995; 267: 1178–1183
  • Klein-Schneegans A S, Kuntz L, Tremhleau S, Fonteneau P, Loor F. Serum concentrations of IgM, IgG1, IgG2b, IgG3 and IgA in C57BL/6 mice and their congenics at the nu (nude) locus. Thymus 1990; 16: 45–54
  • Koller B H, Smithies O. Inactivating the b˜2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc Natl Acad Sci USA 1989; 86: 8932–8935
  • Kyuwa S, Stohlman S A. Pathogenesis of a neurotropic murine coronavirus, strain JHM in the central nervous system of mice. Sem Virol 1990; 1: 273–280
  • Lavi E, Weiss S R. Clinical and Molecular Aspects of Neurotropic Virus Infection. Kluwer Academic Publishers, Boston 1989; 101–139, Coronaviruses. In: Gilden DH, Lipton HL, (eds)
  • Lehmann-Grube F, Lohler J, Utermohlen O, Gegin C. Antiviral immune responses of lymphocytic choriomeningitis virus-infected mice lacking CD8+ T lymphocytes because of disruption of the b˜2-microglobulin gene. J. Virol 1993; 67: 332–339
  • Martin J R, Nathanson N. Animal models of virus-induced demyelination. Prog Neuropathol 1979; 4: 27–50
  • Nonoyama S, Smith F O, Bernstein I D, Ochs H D. Strain-dependent leakiness of mice with severe combined immune deficiency. J. Immunol 1993; 150: 3817–3824
  • Pearce B D, Hobbs M V, McGraw T S, Buchmeier M J. Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J. Virol 1994; 68: 5483–5495
  • Perlman S, Schelper R, Bolger E, Ries D. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody. Microb Pathog 1987; 2: 185–194
  • Raulet D H. MHC class I-deficient mice. Adv Immunol 1994; 55: 381–421
  • Rocha B, Vassalli P, Guy-Grand D. The extrathymic T-cell development pathway. Immunol Today 1992; 13: 449–454
  • Schwender A, Hein A, Imrich H Dorries. Coronaviruses. Plenum Press, New York 1994; 425–430, On the role of different lymphocyte subpopulations in the course of coronavims MHV IV (JHM)-induced encephalitis in Lewis rats. In: Laude H, Vautherot JF, (eds)
  • Sorensen O, Dugre R, Percy D, Dales S. In vivo and in vitro models of demyelinating disease: Endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice. Infect Immun 1982; 37: 1248–1260
  • Sorensen O, Saravani A, Dales S. In vivo and in vitro models of demyelinating disease. XVII. The infectious process in athymic rats inoculated with JHM virus. Microb Pathog 1987; 2: 79–90
  • Spriggs M K, Koller B H, Sato T, Morrissey P J, Fanslow W C, Smithies O, Voice R F, Widmer M B, Maliszewski C R. b˜2-Microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci USA 1992; 89: 6070–6074
  • Stohlman S A, Bergmann C C, van der Veen R C, Hinton D R. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J. Virol 1995; 69: 684–694
  • Stohlman S A, Matsushima G K, Casteel N, Weiner L P. In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. J. Immunol 1986; 136: 3052–3056
  • Stohlman S A, Sussman M A, Matsushima G K, Shubin R, Erlich S S. Delayed-type hypersensitivity response in the central nervous system during JHM virus infection requires viral specificity for protection. J Neuroimmunol 1988; 19: 255–268
  • Sussman M A, Shubin R A, Kyuwa S, Stohlman S A. T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J. Virol 1989; 63: 3051–3056
  • Wang F I, Fleming J O, Lai M MC. Sequence analysis of the spike protein gene of murine coronavirus variants: Study of genetic sites affecting neuropathogenicity. Virology 1992a; 186: 742–749
  • Wang F I, Hinton D R, Gilmore W, Trousdale M D, Fleming J O. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab Invest 1992b; 6: 744–754
  • Wang F I, Stohlman S A, Fleming J O. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J. Neuroimmunol 1990; 30: 31–41
  • Weiner L P. Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus). Arch Neurol 1973; 28: 298–303
  • Williamson J SP, Stohlman S A. Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J. Virol 1990; 64: 4589–4592
  • Williamson J SP, Sykes K C, Stohlman S A. Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J. Neuroimmunol 1991; 32: 199–207
  • Yamaguchi K, Goto N, Kyuwa S, Hayami M, Toyoda Y. Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones. J. Neuroimmunol 1991; 32: 1–9
  • Yokomori K, Baker S C, Stohlman S A, Lai M MC. Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus. J. Virol 1992; 66: 2865–2874
  • Zimmer M J, Dales S. In vivo, in vitro models of demyelinating diseases XXIV. The infectious process in cyclosporin A treated Wistar Lewis rats inoculated with JHM virus. Microb Pathog 1989; 6: 7–16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.